Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that the United States Food and Drug Administration (“FDA”) has granted Orphan Drug Designation…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the start of vehicle production at its Tunica, Mississippi, assembly plant for the Mullen THREE, Class 3 EV truck with first customer deliveries…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced that one of its K5 ASRs is now patrolling the parking lot of a mixed-use facility in…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, recently announced its intent to conduct a human clinical study to examine its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) for diabetes control and weight loss.…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting results from its 2023 human oral nicotine study NIC-H22-1. The study compared Lexaria’s DehydraTECH(TM)-Nicotine tobacco-free pouch to two world-leading brands: ZYN(R) and…
Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness, today announced data from a recent clinical study of NoStingz, its proprietary topical sunscreen formulated to protect users from jellyfish, sea lice and…
HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, allowing for the creation of rich data for AI.…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that it delivered on yet another important milestone in deploying its first two K1 Hemisphere ASRs…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced a 1 for 9 reverse split. According to the announcement, the company plans to repurchase up to $25 million in shares through a…
HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, allowing for the creation of rich data for AI.…
CISO Global Inc. (NASDAQ: CISO), has unveiled Argo Edge, a powerful tool stack the company has been developing and testing for the past two years. According to the announcement, Argo Edge combines the most sought-after…
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has released its financial and corporate report for the second quarter, the period ended June 30, 2023. Financial highlights of the report include…
When Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, announced receipt of an Australian patent on March 8, 2022 (https://ibn.fm/OobWl), its resolve to continue expanding its intellectual property (“IP”), particularly within the…
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, is collaborating with Davidson Technologies Inc. to create innovative new solutions to complex problems in the defense and aerospace sectors. Davidson Technologies…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced plans to hold its Second Quarter Town Hall Update to share current events and 2023 financial…
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a supply chain innovator, recently welcomed an extensive new pool of truck drivers working within the United States-Mexico-Canada Agreement (“USMCA”) trade area, expanding the reach of its platform and increasing…
CNS Pharmaceuticals (NASDAQ: CNSP), a Texas-based cancer drug innovator, is focused on advancing its potentially pivotal clinical trial to track the effectiveness of drug candidate Berubicin in treating glioblastoma (“GBM”) brain cancers. Berubicin has already…
Fintech Ecosystem Development (NASDAQ: FEXD), a special purpose acquisition company (“SPAC”), is focused on the changing consumer landscape and how digital payments are shaping the way people transact. In response, the company is pushing for…
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, focused on delivering customer value via practical quantum applications, has announced a collaboration with QuantumBasel and VINCI Energies, an accelerator of environmental…